Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Prentice

Showing results (191-200 of 299) with videos related to

Pageof 30
Sort By:
Bone Marrow Transplantation|November 1, 1995
Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplantT J Corbett, H Saw, U Popat, et al.
Transplantation|April 1, 1981
Immunological characterization of hemopoietic cells in the common marmoset, rhesus monkey, and man. In search of a model for human marrow transplantationD H Crawford, G Janossy, C M Hetherington, et al.
Blood|December 15, 1990
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipientsD J Gottlieb, S J Cryz, E Furer, et al.
Lancet (London, England)|November 26, 1977
Maintenance of remission in acute myelogenous leukaemia by a mixture of B.C.G. and irradiated leukaemia cellsR L Powles, J A Russell, P J Selby, et al.
Journal of Medical Virology|April 1, 1988
Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseasesN J Berry, D M Burns, G Wannamethee, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1982
The pharmacokinetics of ketoconazole in severely immunocompromised patientsI M Hann, H G Prentice, M Keaney, et al.
Blood|December 9, 1998
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejectionG Hale, M J Zhang, D Bunjes, et al.
British Journal of Haematology|June 1, 1989
Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapyH E Heslop, D J Gottlieb, J E Reittie, et al.
Lancet (London, England)|December 1, 1984
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent fociP D Griffiths, D D Panjwani, P R Stirk, et al.
Blood|September 1, 1990
Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirusA S Duncombe, A Meager, H G Prentice, et al.
Pageof 30

Showing results (191-200 of 299) with videos related to

Sort By:
Pageof 30
Bone Marrow Transplantation|November 1, 1995
Successful treatment of parvovirus B19 infection and red cell aplasia occurring after an allogeneic bone marrow transplantT J Corbett, H Saw, U Popat, et al.
Transplantation|April 1, 1981
Immunological characterization of hemopoietic cells in the common marmoset, rhesus monkey, and man. In search of a model for human marrow transplantationD H Crawford, G Janossy, C M Hetherington, et al.
Blood|December 15, 1990
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipientsD J Gottlieb, S J Cryz, E Furer, et al.
Lancet (London, England)|November 26, 1977
Maintenance of remission in acute myelogenous leukaemia by a mixture of B.C.G. and irradiated leukaemia cellsR L Powles, J A Russell, P J Selby, et al.
Journal of Medical Virology|April 1, 1988
Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseasesN J Berry, D M Burns, G Wannamethee, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1982
The pharmacokinetics of ketoconazole in severely immunocompromised patientsI M Hann, H G Prentice, M Keaney, et al.
Blood|December 9, 1998
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejectionG Hale, M J Zhang, D Bunjes, et al.
British Journal of Haematology|June 1, 1989
Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapyH E Heslop, D J Gottlieb, J E Reittie, et al.
Lancet (London, England)|December 1, 1984
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent fociP D Griffiths, D D Panjwani, P R Stirk, et al.
Blood|September 1, 1990
Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirusA S Duncombe, A Meager, H G Prentice, et al.
Pageof 30